- Details
- Description
Packaging Size:
30 tablets
Strength:
150 mg
Composition:
Tucatinib INN
Treatment:
Anti-Cancer / Oncology
Form:
Tablet
Brand:
TUKANIC
Quantity Unit:
Tablets
Manufacturer:
Ziska Pharmaceuticals Limited
TUKANIC (Tucatinib INN) is an oral targeted anti-cancer medicine containing tucatinib, a selective HER2 tyrosine kinase inhibitor that blocks HER2 signaling involved in cancer cell growth and spread. It is used in combination with other anticancer medicines for the treatment of HER2-positive breast cancer, including advanced or metastatic disease. TUKANIC is available in a 30-tablet pack and is classified as an anti-cancer medicine.
